journal article·2025-01

Synergistic phototherapy using chitosan-enhanced antimonene nanosheets for effective cancer treatment

Ziying Zhang, Feng Liu, Jiale Li, Bing Wang

Journal of Nanoparticle Research· Volume 27· Issue 1
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (57)

Show source-provided references
1. Tacar O, Sriamornsak P, Dass CR (2013) Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 65(2):157–17010.1111/j.2042-7158.2012.01567.x ↗
2. Ferlay J, Colombet M, Soerjomataram I et al (2021) Cancer statistics for the year 2020: an overview. Int J Cancer 149(4):778–78910.1002/ijc.33588 ↗
3. Jassim A, Rahrmann EP, Simons BD et al (2023) Cancers make their own luck: theories of cancer origins[J]. Nat Rev Cancer 23(10):710–72410.1038/s41568-023-00602-5 ↗
4. Apetoh L, Ghiringhelli F, Tesniere A et al (2007) Toll-like resceptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy[J]. Nat Med 13(9):1050–105910.1038/nm1622 ↗
5. Olive KP, Jacobetz MA, Davidson CJ et al (2009) Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer[J]. Science 324(5933):1457–146110.1126/science.1171362 ↗
6. Hamim Z, Wang Y, Luay N et al (2016) Monovar: single-nucleotide variant detection in single cells[J]. Nat Methods 13:505–50710.1038/nmeth.3835 ↗
7. Claudia AP, Loris M, Muiños F et al (2019) OncodriveCLUSTL: a sequence-based clustering method to identify cancer drivers[J]. Bioinformatics 35(24):539610.1093/bioinformatics/btz588 ↗
8. Wu RY, Xu JH (2017) Research progress on chemotherapy-induced tumor microenvironment changes and tumor metastasis[J]. Chin J Clin Oncol 44(20):1049–1054
9. Zeng J, Yang L, Zeng L, et al (2024) Visualizing cancer resistance via nano-quenching and recovery detector of CD44[J]. J Nanobiotechnol 22(1):45210.1186/s12951-024-02732-w ↗
10. Liang S, Liu YF, Zhu HQ, et al (2024) Emerging nitric oxide gas‐assisted cancer photothermal treatment. Exploration 27610.1002/EXP.20230163 ↗
11. Zhao L, Zhang X, Wang X et al (2021) Recent advances in selective photothermal therapy of tumor[J]. J Nanobiotechnol 19(1):33510.1186/s12951-021-01080-3 ↗
12. Zhang C, Xia D, Liu J, et al (2020) Bypassing the immunosuppression of myeloid‐derived suppressor cells by reversing tumor hypoxia using a platelet‐inspired platform[J]. Adv Funct Mater 30(22)10.1002/adfm.202000189 ↗
13. Chen X, Chen L, Li D (2019) Research progress of gene therapy in clinical application[J]. Chin J Biotechnol 35(12):2295–2307
14. Kooten CV, Gelderman KA (2011) In vitro-generated DC with tolerogenic functions: perspectives for in vivo cellular therapy[J]. Methods Mol Biol 677:14910.1007/978-1-60761-869-0_10 ↗
15. Kon E, Ad-El N, Hazan-Halevy I et al (2023) Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects. Nat Rev Clin Oncol 20:739–75410.1038/s41571-023-00811-9 ↗
16. Li XD, Lan YF, Fu X, et al (2024) DNA nanomachine-driven chemodynamic therapy against glioblastoma[J]. Aggregate 5(6)10.1002/agt2.603 ↗
17. Lan YF, Li XD, Liu BY, et al. (2024) Framework nucleic acid-based nanoparticles enhance temozolomide sensitivity in glioblastoma[J]. Drug Resistance Updates 76:10112210.1016/j.drup.2024.101122 ↗
18. Dahri M, Beheshtizadeh N, Seyedpour N et al (2023) Biomaterial-based delivery platforms for transdermal immunotherapy[J]. Biomed Pharmacother 165:11504810.1016/j.biopha.2023.115048 ↗
19. Kessel D (2019) Photodynamic therapy: a brief history[J]. J Clin Med 8(10):158110.3390/jcm8101581 ↗
20. Zhao LH, Li M, Shen C, et al (2024) Orally administrated hydrogel harnessing intratumoral microbiome and microbiota-related immune responses for potentiated colorectal cancer treatment[J]. Research 710.34133/research.0364 ↗
21. Wu K, Zhao H, Sun Z et al (2019) Endogenous oxygen generating multifunctional theranostic nanoplatform for enhanced photodynamic-photothermal therapy and multimodal imaging[J]. Theranostics 9(25):7697–771310.7150/thno.38565 ↗
22. He JW, Song RX, Xiao FF et al (2023) Cu3P/1-MT nanocomposites potentiated photothermal-immunotherapy[J]. Int J Nanomed 6(18):3021–3033
23. Dash SR, Kundu C (2021) Photothermal therapy: a new approach to eradicate cancer[J]. Curr Nanosci 18(1):31–4710.2174/1573413717666210301112058 ↗
24. Weng XL, Liu JY (2021) Strategies for maximizing photothermal conversion efficiency based on organic dyes[J]. Drug Discov Today 26(8):2045–205210.1016/j.drudis.2021.03.009 ↗
25. Ding Z, Gu Y, Zheng C et al (2022) Organic small molecule-based photothermal agents for cancer therapy: design strategies from single-molecule optimization to synergistic enhancement[J]. Coord Chem Rev 464:21456410.1016/j.ccr.2022.214564 ↗
26. Riley RS, Day ES (2017) Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment[J]. Wiley Interdiscip Rev Nanomed Nanobiotechnol 9(4):e144910.1002/wnan.1449 ↗
27. Fan W, Yung B, Huang P et al (2017) Nanotechnology for multimodal synergistic cancer therapy[J]. Chem Rev 117(22):13566–1363810.1021/acs.chemrev.7b00258 ↗
28. Wang Q, Dai Y, Xu J et al (2019) All-in-one phototheranostics: single laser triggers NIR-II fluorescence/photoacoustic imaging guided photothermal/photodynamic/chemo combination therapy[J]. Adv Funct Mater 29(31):190148010.1002/adfm.201901480 ↗
29. Xiao M, Guo JX et al (2018) Synchronous delivery of oxygen and photosensitizer for alleviation of hypoxia tumor microenvironment and dramatically enhanced photodynamic therapy[J]. Drug Deliv 25(1):585–59910.1080/10717544.2018.1435751 ↗
30. Ma Y, Zhao X, Tian P et al (2024) Laser-ignited lipid peroxidation nanoamplifiers for strengthening tumor photodynamic therapy through aggravating ferroptotic propagation and sustainable high immunogenicity[J]. Small 20(14):230640210.1002/smll.202306402 ↗
31. Alzeibak R, Mishchenko TA, Shilyagina NY et al (2021) Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future[J]. J Immunother Cancer 9(1):192610.1136/jitc-2020-001926 ↗
32. Niu N, Yu Y, Zhang Z et al (2022) A cell membrane-targeting AIE photosensitizer as a necroptosis inducer for boosting cancer theranostics[J]. Chem Sci 13:5929–593710.1039/D2SC01260J ↗
33. Hirsch LR, Stafford RJ, Bankson JA et al (2003) Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance[J]. Proc Natl Acad Sci USA 100:13549–1355410.1073/pnas.2232479100 ↗
34. Emiliano MP, Down MP, Gibaja C et al (2018) Antimonene: a novel 2D nanomaterial for supercapacitor applications[J]. Adv Energy Mater 8(11):170260610.1002/aenm.201702606 ↗
35. Liu YL et al (2017) Tumor-triggered drug release from calcium carbonate-encapsulated gold nanostars for near-infrared photodynamic/photothermal combination antitumor therapy[J]. Theranostics 7(6):1650–166210.7150/thno.17602 ↗
36. Zhang LS, Hu JQ, Chen ZG (2012) Research progress in gold nanostructures with photothermal effects[J]. Mater Rev 26:5–9
37. Romero MP, Buzza H, Azevedo MDSD et al (2024) Graphene oxide theranostic effect: conjugation of photothermal and photodynamic therapies based on an in vivo demonstration[J]. Int J Nanomedicine 16:1601–161610.2147/IJN.S287415 ↗
38. Yang YM, Yan JY, Hu WN (2012) The application of graphene and its derivatives in tumor diagnosis and treatment[J]. Genomics Appl Biol 26:5–9
39. Xue P, Yang R, Sun L et al (2018) Indocyanine green-conjugated magnetic Prussian blue nanoparticles for synchronous photothermal/photodynamic tumor therapy[J]. Nano-Micro Lett 10(4):7410.1007/s40820-018-0227-z ↗
40. Tang F, Li L, Chen D (2012) Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery[J]. Adv Mater 24(12):1504–153410.1002/adma.201104763 ↗
41. Nazir S, Hussain T, Ayub A et al (2014) Nanomaterials in combating cancer: therapeutic applications and developments[J]. Nanomedicine 10(1):19–3410.1016/j.nano.2013.07.001 ↗
42. Wen P, Shi F (2021) Research progress of nanomaterials in tumor therapy[J]. Anti-tumor Pharmac 11(2):153–157
43. Adil W (2023) Fabrication and applications of 2D few-layer antimonene: an overview[J]. J Inst Eng India Ser A 104(1):403–41210.1007/s40033-022-00387-1 ↗
44. Fickert M, Assebban M, Canet-Ferrer J, et al (2021) Phonon properties and photo-thermal oxidation of micromechanically exfoliated antimonene nanosheets[J]. 2D Mater 8(1):01501810.1088/2053-1583/abb877 ↗
45. Gao Y, Liu Y, Li X et al (2024) A stable openshell conjugated diradical polymer with ultrahigh photothermal conversion efficiency for NIR-II photoimmunotherapy of metastatic tumor[J]. Nano-Micro Lett 16(2):1–14
46. Krishnaveni B (2016) Chitosan: a review on its varied novel therapeutic and industrial applications[J]. J Drug Deliv Ther 6:70–79
47. Kou SG, Peters LM, Mucalo MR (2021) Chitosan: a review of sources and preparation methods[J]. Int J Biol Macromol 169:85–9410.1016/j.ijbiomac.2020.12.005 ↗
48. Yan B, Dai Y, Xin L et al (2024) Research progress in the degradation of printing and dyeing wastewater using chitosan based composite photocatalytic materials[J]. Int J Biol Macromol 263:13008210.1016/j.ijbiomac.2024.130082 ↗
49. Alemu D, Getachew E, Mondal A (2023) Study on the physicochemical properties of chitosan and their applications in the biomedical sector[J]. Int J Polym Sci 202310.1155/2023/5025341 ↗
50. Tao W, Ji X, Xu X et al (2017) Antimonene quantum dots: synthesis and application as near-infrared photothermal agents for effective cancer therapy[J]. Angew Chem Int Ed Engl 56(39):11896–1190010.1002/anie.201703657 ↗
51. Guo D, Liu BB, Zhang TT, Wang J, Zou LL (2022) Research progress of chlorin e6 and its photodynamic therapy on tumor[J]. Chin J Mod Appl Pharm 39(14):1908–1916
52. Witzigmann, Dominik, Wicki, et al (2015) Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications[J]. J Controlled Release Official J Controlled Release Soc. 200(2015):138–5710.1016/j.jconrel.2014.12.030 ↗
53. Li HY, Xu H, Huang YY (2023) Preparation of compound high water-soluble chlorin-based photosensitizer and its photodynamic cell therapy performance test[J]. J Xuzhou Med Univ 43(1):27–32
54. Wang C, Tao H, Cheng L et al (2011) Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles[J]. Biomaterials 32(26):6145–615410.1016/j.biomaterials.2011.05.007 ↗
55. Tao W, Ji X, Zhu X, et al (2018) Cancer theranostics: two‐dimensional antimonene‐based photonic nanomedicine for cancer theranostics [J]. Adv Mater 30(38):e180206110.1002/adma.201802061 ↗
56. Yu JW, Wang XH, Feng JC et al (2020) Antimonene nanoflakes as a photoacoustic imaging contrast agent for tumor in vivo imaging[J]. CJOL 47(2):0207033
57. Laghrib F, Ajermoun N, Bakasse M, Lahrich S, El Mhammedi MA (2019) Synthesis of silver nanoparticles assisted by chitosan and its application to catalyze the reduction of 4-nitroaniline[J]. IJBM 135:752–75910.1016/j.ijbiomac.2019.05.209 ↗